Cargando…

1565MO Time-dependent improvement in the clinical outcomes from COVID-19 in cancer patients: An updated analysis of the OnCovid registry

Detalles Bibliográficos
Autores principales:	Pinato, D.J., Patel, M., Lambertini, M., Colomba, E., Pommeret, F., Van Hemelrijick, M., Zambelli, A., Newsom-Davis, T., Salazar, R., Bertuzzi, A., Gaidano, G., Rizzo, G., Patel, G., Felip, E., Prat, A., Aguilar-Company, J., Tabernero, J., Diamantis, N., Gennari, A., Cortellini, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454391/ http://dx.doi.org/10.1016/j.annonc.2021.08.1558

Ejemplares similares

237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
por: Cortellini, A., et al.
Publicado: (2022)

Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry
por: Cortellini, Alessio, et al.
Publicado: (2022)

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
por: Garrigós, Laia, et al.
Publicado: (2021)

COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
por: Cortellini, Alessio, et al.
Publicado: (2022)

504P SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer
por: Pinato, D.J., et al.
Publicado: (2022)

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
por: Cortellini, Alessio, et al.
Publicado: (2022)

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
por: Pinato, David J, et al.
Publicado: (2021)

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
por: Dettorre, Gino M, et al.
Publicado: (2021)

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
por: Pinato, David J, et al.
Publicado: (2022)

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
por: Cortellini, Alessio, et al.
Publicado: (2023)

The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer
por: Dettorre, G.M., et al.
Publicado: (2021)

1679P Determinants of mortality from SARS-CoV-2 infection in European cancer patients
por: Pinato, D.J., et al.
Publicado: (2020)

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
por: Cortellini, Alessio, et al.
Publicado: (2022)

318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
por: Pinato, D.J., et al.
Publicado: (2020)

319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection
por: Dettorre, G., et al.
Publicado: (2020)

The f2(1565) in pbar-p -> (omega-omega)pizero interactions at rest
por: Baker, C.A., et al.
Publicado: (2011)

The $f_{2}(1565)$ in $\overline{P}p \to (\omega \omega)\pi^{0}$ interactions at rest
por: Baker, C A, et al.
Publicado: (1999)

Observation of an isoscalar meson AX(1565) in annihilation of the $\overline{p}p$-atom from P states
por: May, B, et al.
Publicado: (1989)

1750P Clinical course and outcome of COVID-19 in cancer patients: Early results from the “onCOVID-19” study
por: Di Noia, V., et al.
Publicado: (2020)

Study of the $f_{0}(1500) f_{2} (1565)$ production in the exclusive annihilation $np \to \pi^{+} \pi^{+} \pi^{-}$ in flight
por: Bertin, A, et al.
Publicado: (1998)

P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND REDUCES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
por: van Beers, E. J., et al.
Publicado: (2022)

1565. Lymphocyte Subsets as Predictors of Cytomegalovirus Infection After Transplantation
por: Meesing, Atibordee, et al.
Publicado: (2018)

1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19
por: Patel, M., et al.
Publicado: (2021)

Don Diego Quijada alcalde mayor de Yucatán, 1561-1565.
Publicado: (1938)

1565. Antiretroviral Stewardship: Protocol Development and Implementation at an Academic Medical Center.
por: Bylsma, Tara, et al.
Publicado: (2023)

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
por: Pinato, David J., et al.
Publicado: (2021)

1565. Characterization of Tebipenem (SPR859) Pharmacokinetics–Pharmacodynamics (PK-PD) for Efficacy Against Enterobacteriaceae in a One-Compartment In Vitro Infection Model
por: VanScoy, Brian D, et al.
Publicado: (2019)

1696P Incidence of influenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study
por: Grossi, F., et al.
Publicado: (2020)

PO-1472 OnCovid!: a project to ensure continuity and adequate quality of oncological care during the COVID-19 pandemic
por: Verheij, M., et al.
Publicado: (2021)

MT15 Obvio-19 App Ease of Use of Cancer Patients for Reporting COVID-19 Symptomology (ONCOVID Study)
por: Heidman, M, et al.
Publicado: (2022)

A novel 1565 nm non-ablative fractional device for stretch marks: A preliminary report
por: Tretti Clementoni, Matteo, et al.
Publicado: (2015)

Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study
por: De Jaeghere, Emiel A., et al.
Publicado: (2022)

1671MO Provision of palliative care for patients with cancer and SARS-CoV-2 infection
por: Soosaipillai, G.B., et al.
Publicado: (2020)

P1565: INCIDENCE OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH B-LINEAGE LYMPHOMA RECEIVING CHEMOTHERAPY CONTAINING RITUXIMAB
por: Liang, Xiping Xiping, et al.
Publicado: (2023)

Milano Policlinico ONCOVID modified Score for risk evaluation in oncology during the COVID-19 pandemic: a prospective monocentric study
por: Ben Kridis, Wala, et al.
Publicado: (2022)

Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
por: Pommeret, F., et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
por: Pinato, David J., et al.
Publicado: (2022)

RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 2023, 15, 1565
por: Wiesinger, Anna-Maria, et al.
Publicado: (2023)

1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
por: Pous, A., et al.
Publicado: (2021)

1565 Identifying Optimal HIV Viral Load (VL) Thresholds for Predicting Antiretroviral Treatment Failure (TF) Using ROC Curve Analysis
por: Luo, Robert, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_skhir2u28bs0f6akpubom92ib0